27 Dec, EOD - Indian

SENSEX 78699.07 (0.29)

Nifty 50 23813.4 (0.27)

Nifty Bank 51311.3 (0.27)

Nifty IT 43721.4 (0.13)

Nifty Midcap 100 56979.8 (-0.26)

Nifty Next 50 68557.15 (-0.88)

Nifty Pharma 23008.35 (1.30)

Nifty Smallcap 100 18755.85 (0.15)

27 Dec, EOD - Global

NIKKEI 225 40281.16 (1.80)

HANG SENG 20090.46 (-0.04)

S&P 6041.25 (-1.08)


Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(09 Dec 2024, 13:55)

Star Health drops after IRDAI issues show cause notice

Star Health and Allied Insurance Company dropped 3.90% to Rs 469.60 after the company received showcause notice from the insurance regulator.


The Insurance Regulatory and Development Authority of India (IRDAI) has issued a show cause notice to Star Health and Allied Insurance Company for alleged violations of various IRDAI regulations and guidelines. The notice follows an inspection IRDAI conducted for the period from January 31, 2022 to February 11, 2022 and the observations it made pertaining to the company’s business and operational aspects.

The company is in the process of submitting response to the observations, Star Health said in filing. The company has been advised to reply within 21 days from the date of receipt of the notice along with supporting documents. It is in the process of providing adequate replies to the alleged violations and believes that there will not be any impact. However, the outcome and related implications cannot be predicted with certainty at this stage, the insurer said.

The company was undertaking internal assessments with regard to the impact because of the show cause notice.

Star Health is a standalone health insurer, offering a variety of products including health, personal accident, and travel insurance. The company has a strong distribution network and have settled over 1 crore claims. In FY24, they reported a gross written premium of Rs 15,254 crore and a net worth of Rs 6,339 crore.

The company’s net profit fell 11.18% to Rs 111.29 crore on 17.2% increase in total income to Rs 4060.62 crore in Q2 FY25 over Q2 FY24.


More News